Equity Details
Price & Market Data
Price: $8.57
Daily Change: -$0.065 / 0.76%
Daily Range: $8.18 - $8.95
Market Cap: $234,490,304
Daily Volume: 689,429
Performance Metrics
1 Week: -1.90%
1 Month: -2.48%
3 Months: 8.98%
6 Months: -5.39%
1 Year: -28.82%
YTD: 34.58%
About Arcturus Therapeutics Holdings Inc. (ARCT)
Market summary for Arcturus Therapeutics Holdings Inc. (ARCT). Price: 8.57, daily change: -$0.065 / 0.76%. Market cap: 234,490,304. Performance YTD, 1-month, 3-month.
Company Details
Employees: 111
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.